Wednesday - April 9, 2025
Fisher Clinical Services Seeks DEA Approval to Import Controlled Substances for Clinical Trials
March 15, 2025
WASHINGTON, March 15 (TNSFR) -- Fisher Clinical Services, Inc., Allentown, Pennsylvania, has submitted an application to the Drug Enforcement Administration (DEA) to register as an importer of several controlled substances for use in clinical trials. The company, located at 7554 Schantz Road, seeks authorization to import Schedule I and Schedule II substances, including marijuana, psilocybin, dimethyltryptamine, methylphenidate, and tapentadol.

According to the DEA, Fisher Clinical . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products